In plain words
Of four trials, two in men found testosterone rose more with ashwagandha than with a placebo. One measured it in saliva and the other measured free testosterone in blood. The other two found no difference from placebo, and one of those studied women around menopause. The second trial in men also found no difference in total testosterone.
The short answer
Two of four randomized trials found a rise against placebo; two did not. In 40 overweight men, 600 mg a day for 8 weeks was associated with a 14.7% greater rise in saliva testosterone (Lopresti, 2019). In 56 people on 400 mg a day for 12 weeks, men's free testosterone rose but total did not differ (Smith, 2023). Gopal (2021) found 300 mg twice a day for 8 weeks was not associated with a difference in 100 perimenopausal women. A second Lopresti trial (2019) found no difference against placebo; the ledger has no n, dose or duration for it. Certainty is low, because the trials measured different kinds of testosterone.
Where the evidence sits
Rose more than placebo
No difference from placebo
■ measured by the source's own study · ◪ pooled analysis, may overlap studies counted here · □ reported, reviewed or argued, no new data
Who says what
| Source | Finding | Design | People | Dose and length | Funding and independence |
|---|---|---|---|---|---|
| Lopresti, 2019, men | 14.7% greater saliva rise | Randomized crossover | 40 overweight men | 600 mg daily, 8 weeks | Not in ledger |
| Smith, 2023 | Free rose; total unchanged | Randomized, placebo | 56 | 200 mg twice daily, 12 weeks | Not in ledger |
| Lopresti, 2019, Medicine | Not against placebo | Randomized, placebo | Both sexes | Not in ledger | Not in ledger |
| Gopal, 2021 | No difference | Randomized, placebo | 100 perimenopausal women | 300 mg twice daily, 8 weeks | Not in ledger |
| Gómez Afonso, 2023 | Two studies reported rises | Review of studies | Not in ledger | Not in ledger | Not in ledger |
| NCCIH, 2023 | Possible rise | Agency summary of studies | Not in ledger | 2 to 4 months | US NIH |
14.7% greater saliva rise
Free rose; total unchanged
Not against placebo
No difference
Two studies reported rises
Possible rise
Did men's testosterone rise more than with placebo?
In Lopresti and colleagues' crossover trial (2019), 40 overweight men aged 40 to 70 with mild fatigue took 600 mg a day and a placebo for 8 weeks each, with saliva testosterone measured:
14.7% greater increase in testosterone (p = .010) compared to the placebo
Smith and colleagues (2023) gave 56 people 200 mg twice a day or a placebo for 12 weeks:
In the men taking ashwagandha, there was a significant increase in the blood concentrations of free testosterone (p = 0.048)
Smith's paper reports no group difference in total testosterone.
Did it beat placebo, or only the starting level?
A second Lopresti trial (2019, Medicine) compared people with their starting levels and with placebo; the ledger has no n, dose or duration for it:
Testosterone levels increased in males ( P = .038) but not females ( P = .989) over time, although this change was not statistically significant compared with the placebo ( P = .158).
Gopal and colleagues (2021) gave 100 perimenopausal women 300 mg twice a day or a placebo for 8 weeks:
There was no significant between the group differences in the serum testosterone level.
What do the reviews say?
Gómez Afonso and colleagues (2023) reviewed published studies that may include the trials above, so it adds no measurement; the ledger has no n or dose for them:
Two studies reported significant increases in testosterone levels in the Ashwagandha intervention group relative to the control [15, 39].
NCCIH, part of the US National Institutes of Health, summarized others' studies in 2023, with no n or dose in the ledger:
There is some limited evidence that suggests that taking ashwagandha for 2 to 4 months may increase testosterone levels and sperm quality.
Why the sources disagree
The comparison differs: in the Medicine trial, men's testosterone rose against starting levels but not against placebo, and NCCIH's comparison is not in the ledger. The measure differs: saliva testosterone in the crossover trial, free and total blood testosterone in Smith's, serum testosterone in Gopal's. The people differ, from overweight men to perimenopausal women. Trials with n in the ledger (40 to 100 people) gave 400 to 600 mg a day for 8 to 12 weeks. No trial's funding source is in the ledger.
What would settle it
A preregistered, placebo-controlled trial in several hundred men, run by a group with no ties to an extract maker, giving 600 mg a day for 12 weeks and reporting total and free blood testosterone against placebo at 0, 8 and 12 weeks, with women analyzed separately. A matching result from a second independent group would raise certainty from low to moderate.
How this page was made
The 6 sources are four randomized trials and one review found by searching PubMed, plus the NCCIH fact sheet. Ledger studies of ashwagandha on sleep, anxiety and side effects were left out. Every claim was copied word for word into the Longevity Circle ledger and checked against the original text, and a person approved each one. "Contested" means independent trials point in both directions; certainty follows the GRADE levels used in medical reviews. Drafting was assisted by AI.
Changelog: 23 Sep 2026, first version, 6 sources.
